Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collagenase Chemonucleolysis vs Percutaneous Endoscopic Lumbar Discectomy (PELD) for Lumbar Disc Herniation, a Randomized Controlled Trial

NCT05330806 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT05330806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collagenase Chemonucleolysis vs Percutaneous Endoscopic Lumbar Discectomy (PELD) for Lumbar Disc Herniation, a Randomized Controlled Trial
Lead sponsor
Shenzhen People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2021
Completion date
June 28, 2023
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar disc herniation